政策动向 商保创新药目录首次纳入医保调整方案 国家医保局近日印发《2025年基本医保目录及商保创新药目录调整申报操作指南》(下称"《指南》"),首次将商业健康保险创新药目录纳入调整方案。值得注意的是,从丙类目录到商保创新药目录,业内认为,目录从设计逻辑到行业定位均经历了重大调整:商业保险公司退出价格谈判环节,目录性质转向"推荐清单",医保部门将主导药品准入与价格保密协商。 药械审批 科笛集团...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.